David Rivadeneira named director of Northwell Health Cancer Institute at Huntington

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

David Rivadeneira was named director of the Northwell Health Cancer Institute at Huntington. For the past seven years, Rivadeneira has led surgical services and colorectal surgery at Huntington Hospital.

Rivadeneira specializes in laparoscopic, and other minimally invasive procedures including advanced robotic procedures for the treatment of colon and rectal diseases, including cancer. He is a professor of surgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.

Table of Contents

YOU MAY BE INTERESTED IN

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL). 
Over the past three decades, cancer genetics has transformed precision oncology. Germline testing has advanced from single-gene Sanger sequencing to parallel sequencing of hundreds of genes, while tumor (somatic) testing has expanded with the rise of targeted therapies based on point mutations, copy number changes and other alterations. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login